194 related articles for article (PubMed ID: 36263706)
1. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1
Cai DH; Chen BH; Liu QY; Le XY; He L
Dalton Trans; 2022 Nov; 51(43):16574-16586. PubMed ID: 36263706
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate.
Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY
Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids.
Chen BH; Pan ZY; Feng WW; Liu QY; Liu Y; He L
Dalton Trans; 2023 Jun; 52(23):8040-8050. PubMed ID: 37227152
[TBL] [Abstract][Full Text] [Related]
4. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
[TBL] [Abstract][Full Text] [Related]
5. Sparfloxacin - Cu(II) - aromatic heterocyclic complexes: synthesis, characterization and
Liu QY; Qi YY; Cai DH; Liu YJ; He L; Le XY
Dalton Trans; 2022 Jun; 51(25):9878-9887. PubMed ID: 35713093
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety.
Massoud SS; Louka FR; Dial MT; Malek AJ; Fischer RC; Mautner FA; Vančo J; Malina T; Dvořák Z; Trávníček Z
Dalton Trans; 2021 Sep; 50(33):11521-11534. PubMed ID: 34346447
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids.
Zhang CL; Liu YX; Zhang XM; Chen S; Shen F; Xiong YH; Liu W; Mao ZW; Le XY
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():414-425. PubMed ID: 30033272
[TBL] [Abstract][Full Text] [Related]
8. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
9. A novel water-soluble Cu(II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms.
Cai DH; Liang BF; Chen BH; Liu QY; Pan ZY; Le XY; He L
J Inorg Biochem; 2023 Sep; 246():112299. PubMed ID: 37354603
[TBL] [Abstract][Full Text] [Related]
10. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
[TBL] [Abstract][Full Text] [Related]
11. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis.
Liu M; Song XQ; Wu YD; Qian J; Xu JY
Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575
[TBL] [Abstract][Full Text] [Related]
12. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
[TBL] [Abstract][Full Text] [Related]
13. Two New Mononuclear Copper(II)-Dipeptide Complexes of 2-(2'-Pyridyl)Benzoxazole: DNA Interaction, Antioxidation and in Vitro Cytotoxicity Studies.
Gan Q; Qi Y; Xiong Y; Fu Y; Le X
J Fluoresc; 2017 Mar; 27(2):701-714. PubMed ID: 27981404
[TBL] [Abstract][Full Text] [Related]
14. Four Cu(ii) complexes based on antitumor chelators: synthesis, structure, DNA binding/damage, HSA interaction and enhanced cytotoxicity.
Liu YH; Li A; Shao J; Xie CZ; Song XQ; Bao WG; Xu JY
Dalton Trans; 2016 May; 45(19):8036-49. PubMed ID: 27071545
[TBL] [Abstract][Full Text] [Related]
15. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.
Qi J; Yao Q; Tian L; Wang Y
Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656
[TBL] [Abstract][Full Text] [Related]
16. Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity.
Lian WJ; Wang XT; Xie CZ; Tian H; Song XQ; Pan HT; Qiao X; Xu JY
Dalton Trans; 2016 May; 45(22):9073-87. PubMed ID: 27163172
[TBL] [Abstract][Full Text] [Related]
17. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
[TBL] [Abstract][Full Text] [Related]
18. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.
Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL
Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805
[TBL] [Abstract][Full Text] [Related]
19. Homo- and heteroleptic trimethoxy terpyridine-Cu(ii) complexes: synthesis, characterization, DNA/BSA binding, DNA cleavage and cytotoxicity studies.
Jain S; Bhar K; Kumar S; Bandyopadhyaya S; Tapryal S; Mandal CC; Sharma AK
Dalton Trans; 2020 Apr; 49(13):4100-4113. PubMed ID: 32141470
[TBL] [Abstract][Full Text] [Related]
20. Two water-soluble copper(II) complexes: synthesis, characterization, DNA cleavage, protein binding activities and in vitro anticancer activity studies.
Lu J; Sun Q; Li JL; Jiang L; Gu W; Liu X; Tian JL; Yan SP
J Inorg Biochem; 2014 Aug; 137():46-56. PubMed ID: 24803026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
